Workflow
钢铁
icon
Search documents
Consolidated Lithium Metals announces exposure of a new Li-bearing pegmatite at its Preissac Project and closes financing
Globenewswire· 2025-07-04 11:30
Core Insights - Consolidated Lithium Metals Inc. (CLM) has initiated its summer 2025 exploration campaign at the Preissac Project, focusing on lithium exploration [1][9] - The company has successfully excavated a trench revealing an 18-meter-wide pegmatite body, confirming the presence of mineralized structures [2][9] - A total of 25 channel samples have been collected for analysis, alongside a comprehensive bio/soil sampling program that included 279 bio and 252 soil samples [5][9] Exploration Program Details - The trench excavated measures 100 meters in length and 30 meters in width, targeting a previously identified lithium soil anomaly [2] - The bio/soil sampling program utilized a 15m-by-15m grid to cover lithium and copper anomalies detected in 2022 [5] - Soil samples were collected from the B-horizon and analyzed using various geochemical methods at IGS Canada [7][8] Financial Update - CLM has closed a non-brokered private placement financing of units at a price of $0.01 per unit, raising gross proceeds of up to $300,000 [9] - A previous tranche of this offering raised $210,000 by issuing 21,000,000 units [9] Company Overview - Consolidated Lithium Metals Inc. is a Canadian junior mining exploration company focused on lithium and copper properties, primarily in Quebec [13]
10% And 7% Yields You Can Trust - 2 High-Quality Dividend Machines I'd Buy Today
Seeking Alpha· 2025-07-04 11:30
Group 1 - The article promotes iREIT on Alpha as a source for in-depth research on various income alternatives including REITs, mREITs, Preferreds, BDCs, MLPs, and ETFs [1] - It highlights the positive feedback from users, with 438 testimonials, most rated 5 stars, indicating high satisfaction with the service [1] Group 2 - The article includes a disclosure stating that the author has no stock or derivative positions in any mentioned companies and has no plans to initiate such positions in the near future [2] - It clarifies that the opinions expressed are solely those of the author and not influenced by any business relationships with the companies mentioned [2] Group 3 - Seeking Alpha emphasizes that past performance does not guarantee future results and that no specific investment recommendations are provided [3] - The article notes that the views expressed may not reflect those of Seeking Alpha as a whole, highlighting the diversity of opinions among its analysts [3]
Auction result of Treasury Bonds - RIKS 29 0917
Globenewswire· 2025-07-04 11:30
Summary of Key Points Core Viewpoint - The auction for RIKS 29 0917 was successful, with a total amount allocated of 7.65 billion and a strong bid-to-cover ratio of 1.92, indicating robust demand for the bonds [1]. Auction Details - **Settlement Date**: The bonds will settle on July 9, 2025 [1]. - **Total Amount Allocated**: 7.65 billion [1]. - **Total Number of Bids Received**: 53 bids were submitted, totaling 14.685 billion [1]. - **Total Number of Successful Bids**: 24 bids were awarded [1]. - **Bid to Cover Ratio**: The ratio stands at 1.92, suggesting that demand exceeded supply [1]. Pricing and Yield Information - **All Bids Awarded At**: The price was 100.376 with a yield of 3.400% [1]. - **Weighted Average of Successful Bids**: The average price was 100.604 with a yield of 3.341% [1]. - **Best Bid**: The highest bid was at a price of 101.190 with a yield of 3.190% [1]. - **Worst Bid**: The lowest bid was at a price of 99.227 with a yield of 3.700% [1]. - **Weighted Average of All Bids Received**: The average price was 100.219 with a yield of 3.441% [1]. Allocation Insights - **Percentage Partial Allocation**: Approximately 100% of bids were allocated in full [1]. - **Lowest Price / Highest Yield Allocated**: The lowest price was 100.376 with a yield of 3.400% [1]. - **Highest Price / Lowest Yield Allocated**: The highest price was 101.190 with a yield of 3.190% [1].
UniFirst Just Went On Sale
Seeking Alpha· 2025-07-04 11:30
Group 1 - UniFirst Corporation's shares experienced a significant decline of 10.2% following the announcement of its third-quarter financial results for 2025 [1] - The company is part of a broader investment service and community focused on cash flow generation in the oil and natural gas sector [1][2] Group 2 - The investment service offers subscribers access to a stock model account, detailed cash flow analyses of exploration and production firms, and live discussions about the sector [2]
东城区发布10条中轴线文化探访线路,首次解锁巴士体验
Xin Jing Bao· 2025-07-04 11:29
"城市V跑 坛城奇遇"线路以微跑的形式进行,从天坛东门开始,穿越天坛公园,再由天坛西门到永定门 广场,约4.5公里,时长约3小时。这条轻运动线路以"天文探奇-建筑解码-烟火拾趣"为脉络,带领参与 者穿越600年历史时空。"坛"即天坛,"城"即永定门,"奇遇"即在文化地标中轻跑漫游,解锁城南旧 事。沿途可以打卡北京市珐琅厂、德必园天坛WE、观坛艺术空间、龙潭中湖公园、龙顺成京作非遗博 物馆、二十四节气公园、京骑咖啡、幸福花市主题邮局等。 "律动巴士 漫阅京彩"线路是一场结合Citywalk(城市漫步)与巴士观光的特色之旅,可深度体验北京的 古韵与今风。线路长约18公里,其中徒步2公里,漫步明城墙遗址公园、三里河绿道,在鲜鱼口品尝老 北京小吃;16公里为巴士游,沿途经过天安门、故宫、钟鼓楼,最后折返到正阳门前结束。 东城区文旅局相关负责人介绍,除了发布10条文化探访线路,还组织了多场沉浸式体验活动。如"城市 V跑 坛城奇遇"探访活动,由2000年悉尼奥运会女子20公里竞走冠军王丽萍担任明星领跑员,现场发布 《东城区文化探访线路倡议书》,邀请更多国内外游客来到北京东城,参与文化探访。在"最美中轴 京 韵无界"体验活 ...
北交所周报:本周整体表现承压,新股上市首秀亮眼-20250704
ZHONGTAI SECURITIES· 2025-07-04 11:29
证券研究报告/行业定期报告 本周整体表现承压,新股上市首秀亮眼 北交所周报(6.23-6.28) 2025 年 07 月 04 日 4)大消费:太湖雪(新国货丝绸第一股)、柏星龙(创意包装第一股)、路斯股份 (北交所宠物食品第一股)、康比特(北交所运动营养第一股)、雷神科技(AI+眼 镜应用领先企业); 5)军工信息化:成电光信(军机升级换代驱动公司特种显示与网络总线业务持续增 长)、星图测控(航天测运控稀缺标的,有望持续受益卫星互联网建设) | 增持(维持) 评级: | | 报告摘要 | | --- | --- | --- | | | | 北交所行情概览: | | | | 1)整体行情:截至 2025年6月28日,北证成份股 268个,平均市值 31.39亿元。 | | 分析师:冯胜 | | 本周北证 50 指数涨跌幅 6.84%,收盘 1439.63点;同期沪深 300、创业板指、科创 | | 执业证书编号:S0740519050004 | | 50 涨跌幅分别为 1.95%、5.69%、3.17%。 | | Email: fengsheng@zts.com.cn | | 2)暴道行情:本周A股涨幅前五的 ...
防线“迅速崩溃”?美国断供弹药 乌军先进武器恐成废铁
Zhong Guo Xin Wen Wang· 2025-07-04 11:28
外媒称,由于无人机的威胁大增,俄军放弃了传统的步坦协同战术,而将部队化整为零,组成一支支十 几人的小分队,在己方无人机掩护下,徒步或骑摩托车对乌军阵地实施穿插攻击。 据英国广播公司7月3日报道,美国暂停向乌克兰运送部分武器,白宫称这样做"符合美国自身利益"。俄 方对此表示欢迎,称有助于更快地结束冲突,乌方则认为该决定"令人痛苦"。 外媒称,特朗普政府以"美军武器库存或降至危险水平"为由,下令将原定交付乌方的数百枚PAC-3防空 拦截弹、"毒刺"便携式防空导弹、"麻雀"空对空导弹、"地狱火"反坦克导弹、精确制导火箭弹和数千发 155毫米炮弹全部扣押。 有分析指出,随着上述弹药停供,从"爱国者"防空系统到F-16战斗机,从"海马斯"火箭炮到155毫米榴 弹炮,乌军装备的大量美制武器可能会变成一堆废铁。 美国有线电视新闻网称,说到底,俄乌较量拼的是后勤保障,尤其看谁的武器装备能及时、足量供应前 线。 外媒称,2021年以来,俄国防工业产能增长10倍,可在一定时间内支撑50万大军的战场消耗。 而同时期,据美国"战区"网站报道,美方一边为乌克兰、以色列提供军援,一边出兵打击胡塞武装、空 袭伊朗核设施,还抽调军力"重返亚 ...
Devon Energy (DVN) Earnings Call Presentation
2025-07-04 11:28
Company Overview - Devon Energy's total production is approximately 820,000 BOED[3] - The company's enterprise value is around $30 billion[3] Asset Portfolio & Production - Delaware Basin production reached 458 MBOED in Q1 2025, representing 47% of the company's total production mix[10, 18, 22] - Rockies production was 195 MBOED in Q1 2025, accounting for 24% of Devon's production mix[10, 23] - Eagle Ford production was 79 MBOED in Q1 2025, constituting 10% of the company's production[10, 30] - Anadarko Basin production was 79 MBOED in Q1 2025, also representing 10% of Devon's production[10, 38] Financial Strength & Returns - Devon Energy has total liquidity of $4.2 billion, including a $1.2 billion cash balance as of March 31, 2025[65] - The company aims to improve pre-tax free cash flow by $1 billion annually through business optimization[55] - Devon Energy plans to return up to 70% of free cash flow to shareholders in 2025[70, 71] - The company anticipates upstream capital investment in Delaware Basin to be approximately $1.9 billion in 2025[21]
Spruce Biosciences (SPRB) Earnings Call Presentation
2025-07-04 11:27
Tralesinidase Alfa (TA-ERT) for MPS IIIB - Tralesinidase Alfa 预计在 2026 年上半年提交 BLA 申请,该项目已准备就绪[8] - MPS IIIB 是一种影响 1/200,000 新生儿的常染色体隐性遗传病[14] - Tralesinidase Alfa 显著且持久地使脑脊液 HS 和 HS-NRE 水平正常化[22] - 早期使用 Tralesinidase Alfa 可稳定 MPS IIIB 患者的认知能力下降[29] - 在为期 48 周的初步研究及其扩展研究中,共进行了约 6,000 次给药,Tralesinidase Alfa 通常具有良好的耐受性[32] Tildacerfont + Cortibon for Major Depressive Disorder (MDD) - Tildacerfont + Cortibon 治疗重度抑郁症 (MDD) 的 2 期研究的顶线数据预计在 2026 年上半年公布[8] - Cortibon 是一种基因选择工具,可基于遗传标记识别 CRHR1 拮抗剂的应答者和非应答者[40] - Cortibon 挑选出约 50% 的显示 HPA 轴功能障碍迹象的 MDD 患者亚群[43] - 在 Cortibon 选择的 MDD 患者群体中,Cohen's d 效应量显著[46] SPR202 & SPR204 - SPR202 是一种用于治疗先天性肾上腺皮质增生症 (CAH) 的抗促肾上腺皮质激素释放激素 (CRH) 单克隆抗体,目前处于 IND 申报阶段[58, 63] - SPR204 是一种用于治疗减重手术后低血糖症的 GLP-1 受体拮抗剂单克隆抗体,目前处于 IND 申报阶段[64, 71] Financials - 截至 2025 年 3 月 31 日,公司拥有 2561.5 万美元的现金和现金等价物,以及 140.2 万美元的债务[74]
长三角发布卫生健康3年行动计划:更侧重医药产业联动、国际开放合作
Di Yi Cai Jing· 2025-07-04 11:27
以优质、均衡的区域一体化医疗服务为基础,长三角在卫生健康领域的三年行动计划将进一步聚焦医学 科技创新、产业协同与联动、国际化开放合作,以及支撑上述工作推进的卫生健康治理机制等。 "现阶段,各地正在谋篇'十五五'重点举措,《行动计划》的发布对于长三角及其他城市规划布局'十五 五'区域卫生健康相关工作起到了先期部署的作用。"华略智库CEO、长三角研究院院长夏骥告诉记者, 百姓在医疗卫生领域的切身感受往往是最强的,"《行动计划》的发布,有利于进一步提升长三角医疗 卫生服务水准,让群众更有获得感。" 夏骥表示,"生物医药"是长三角重点打造的核心产业,《行动计划》所鼓励的生物医药产业发展,具备 鲜明的、区域分工协作的特点,这就需要三省一市在推进跨域生物医药产业发展过程中,围绕各自优势 来进行产业部署、开放合作等,这才会更有利于打造具有全球竞争力的生物医药产业集群。 上海交通大学健康长三角研究院医保研究中心主任李力则表示,一方面,《行动计划》从更协同、更高 效、更便利、更安全等多方面入手,强化了三省一市在医疗服务、公共卫生、健康治理等领域的统筹推 进。 "另一方面,《行动计划》支持医学科技创新与资源共享。长三角区域内的医 ...